window.globalProvideData('caption', '{"data":"WEBVTT%0D%0AKind:%20captions%0D%0ASource:%20Articulate%20Closed%20Captions%20Editor%0D%0ASource%20Version:%203.77.30587.0%0D%0A%0D%0A00:00:00.150%20--%3E%2000:00:04.475%0D%0ARegarding%20intensive%20treatments.%20Treatment%20intensity%20was%20found%20to%20be%20an%20independent%20%0D%0A%0D%0A00:00:04.625%20--%3E%2000:00:08.726%0D%0Apredictor%20of%20inhibitor%20development.%0D%0AMajor%20peak%20treatment%20moments%20which%20%0D%0A%0D%0A00:00:08.876%20--%3E%2000:00:13.327%0D%0Aoccurred%20on%20the%20first%20exposure%20to%20FVIII%20concentrate%20were%20associated%20with%20a%203.3-%0D%0A%0D%0A00:00:13.477%20--%3E%2000:00:17.818%0D%0Afold%20greater%20risk%20of%20inhibitor%20development.%0D%0APatients%20with%20no%20family%20history%20%0D%0A%0D%0A00:00:17.968%20--%3E%2000:00:21.924%0D%0Aof%20hemophilia%20may%20be%20at%20higher%20risk%20due%20to%20intensive%20treatment%20for%20bleeding%20episodes%20%0D%0A%0D%0A00:00:22.074%20--%3E%2000:00:23.510%0D%0Abefore%20diagnosis.%0D%0A%0D%0A%0D%0A"}')